Table 3.
Results of five-fold cross-validation
| k-Fold | Preeclampsia size | Training set | Validation set | |||||
|---|---|---|---|---|---|---|---|---|
| Training set | Validation set | c-Index (95% CI) | sen | spe | c-Index (95% CI) | sen | spe | |
| Fold 1 | 94 | 14 | 0.878 (0.835–0.922) | 0.766 | 0.865 | 0.912 (0.827–0.998) | 0.714 | 0.872 |
| Fold 2 | 83 | 25 | 0.882 (0.838–0.928) | 0.795 | 0.840 | 0.875 (0.787–0.963) | 0.760 | 0.832 |
| Fold 3 | 90 | 18 | 0.881 (0.839–0.923) | 0.711 | 0.910 | 0.885 (0.767–1.000) | 0.778 | 0.919 |
| Fold 4 | 81 | 27 | 0.883 (0.838–0.928) | 0.827 | 0.816 | 0.862 (0.774–0.951) | 0.815 | 0.772 |
| Fold 5 | 84 | 24 | 0.890 (0.844–0.936) | 0.750 | 0.927 | 0.852 (0.771–0.933) | 0.500 | 0.941 |